Trial Profile
Clinical Trials Insight: 700029364
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2007
Price :
$35
*
At a glance
- Drugs IDD 3 (Primary) ; Cyclophosphamide
- Indications Malignant melanoma
- Focus Therapeutic Use
- 19 Dec 2007 New trial record.
- 14 Dec 2007 Initiation of this trial is expected in the next 60 days.